BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4064557)

  • 41. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of phenobarbital on biliary lipid metabolism in cholesterol gallstone subjects.
    Redinger RN
    Lipids; 1979 Mar; 14(3):277-84. PubMed ID: 449630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.
    Henriksson P; Einarsson K; Eriksson A; Kelter U; Angelin B
    J Clin Invest; 1989 Sep; 84(3):811-6. PubMed ID: 2760214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of obesity on bile formation and biliary lipid secretion in the genetically obese JCR:LA-corpulent rat.
    St George CM; Russell JC; Shaffer EA
    Hepatology; 1994 Dec; 20(6):1541-7. PubMed ID: 7982654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of chenic acid on bile lipid composition and on metabolism of bile acids in lithiasis patients].
    Thistle JL
    Minerva Med; 1977 Sep; 68(43):3019-21. PubMed ID: 909649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Gut; 1974 Apr; 15(4):340. PubMed ID: 4834569
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of leptin on biliary lipids: potential consequences for gallstone formation and therapy in obesity.
    Méndez-Sánchez N; Ponciano-Rodrigoez G; Chavez-Tapia N; Uribe M
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):203-8. PubMed ID: 16089354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biliary lipid secretion in health and in cholesterol gallstone disease.
    Carey MC; Mazer NA
    Hepatology; 1984; 4(5 Suppl):31S-37S. PubMed ID: 6479883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary fat alters biliary lipid secretion in the hamster.
    Ohshima A; Cohen BI; Ayyad N; Mosbach EH
    Lipids; 1996 Sep; 31(9):949-54. PubMed ID: 8882974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biliary lipids, bile acids and gallstone formation in hypovitaminotic C guinea-pigs.
    Jenkins SA
    Br J Nutr; 1978 Sep; 40(2):317-22. PubMed ID: 698170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
    Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Braverman DZ; Szczepanik-Van Leeuwen P; Klein PD
    J Lab Clin Med; 1982 Jun; 99(6):798-805. PubMed ID: 7077124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism of increased gallstone formation in obese human subjects.
    Mabee TM; Meyer P; DenBesten L; Mason EE
    Surgery; 1976 Apr; 79(4):460-8. PubMed ID: 1257908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.
    Everson GT; McKinley C; Kern F
    J Clin Invest; 1991 Jan; 87(1):237-46. PubMed ID: 1845870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice.
    Wang DQ
    J Lipid Res; 2002 Nov; 43(11):1950-9. PubMed ID: 12401894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.
    Maton PN; Murphy GM; Dowling RH
    Lancet; 1977 Dec 24-31; 2(8052-8053):1297-301. PubMed ID: 74722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man.
    Bell GD; Doran J; Fayadh M; Murphy G; Dowling RH
    Gut; 1978 Apr; 19(4):300-7. PubMed ID: 648936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.